Not provided
Not provided
Not provided
Not provided
Difficulties encountered in recruiting patients
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Bayer | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In the primary progressive multiple sclerosis, the detection of oligoclonal bands in cerebrospinal fluid is critical for the diagnosis. However, lumbar puncture for cerebrospinal fluid collection is considered relatively invasive. Our hypothesis is that oligoclonal bands detection in tears is possible and useful for the diagnosis of multiple sclerosis.
The objective of the present study is to assess concordance between oligoclonal bands detection in tears and in cerebrospinal fluid. We will include patients with primary progressive multiple sclerosis and we will compare results of oligoclonal bands detection by isoelectric focusing in cerebrospinal fluid and tears. Tears will be collected using a Schirmer strip. This would circumvent the practice of invasive lumbar punctures currently used in multiple sclerosis diagnosis.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Tears sampling | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| tears sampling | Procedure |
|
| Measure | Description | Time Frame |
|---|---|---|
| Concordance between the quantification of oligoclonal IgG bands by isoelectric focusing in tears and in the cerebrospinal fluid in patients with primary progressive multiple sclerosis | at baseline and two years after (+/- 2 months) |
| Measure | Description | Time Frame |
|---|---|---|
| Isoelectrophoretic profile of tears | Determination of the stability and prognostic value of isoelectrophoretic profile of tears at inclusion, after 2 years. | Baseline and two years after inclusion |
| Isoelectrophoretic profiles of tears by digital recording and analysis of images |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Patrick Hautecoeur, MD | Groupement des Hôpitaux de l'Institut Catholique de Lille (GHICL) | Principal Investigator |
| Elisabeth Baumelou, MD | Groupement des Hôpitaux de l'Institut Catholique de Lille | Study Chair |
| Patrick Vermersch, MD, PhD | Centre Hospitalier Régional, Universitaire de Lille | Principal Investigator |
| Christine Lebrun-Frenay, MD, PhD | Centre Hospitalier Universitaire de Nice | Principal Investigator |
| Jérome De Sèze, MD, PhD | Centre Hospitalier Régional Universitaire de Strasbourg | Principal Investigator |
| Thibaut Moreau, MD | Centre Hospitalier Universitaire Dijon | Principal Investigator |
| Pierre Clavelou, MD | Centre Hospitalier Régional Universitaire de Clermont-Ferrand | Principal Investigator |
| Olivier Heinzlef, MD | Centre hospitalier intercommunal de Poissy | Principal Investigator |
| Christian Confavreux, MD | Hospices Civils de Lyon |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Centre hospitalier universitaire (CHU), Nice | Nice | Alpes Maritimes | 06003 | France | ||
| Groupement des Hôpitaux de l'Institut Catholique de Lille (GHICL) |
Not provided
| ID | Term |
|---|---|
| D020528 | Multiple Sclerosis, Chronic Progressive |
| D004194 | Disease |
| D022125 | Lacerations |
| ID | Term |
|---|---|
| D009103 | Multiple Sclerosis |
| D020278 | Demyelinating Autoimmune Diseases, CNS |
| D020274 | Autoimmune Diseases of the Nervous System |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Baseline and two years after |
| Principal Investigator |
| Marc Debouverie, MD, PhD | Central Hospital, Nancy, France | Principal Investigator |
| Jean Pelletier, MD, PhD | L'assistance Publique des Hôpitaux de Marseille | Principal Investigator |
| Bruno Brochet, MD, PhD | University Hospital, Bordeaux | Principal Investigator |
| Gilles Defer, MD | Centre Hospitalier Universitaire de Caen | Principal Investigator |
| Eric Thouvenot, MD | Centre Hospitalier Universitaire de Nīmes | Principal Investigator |
| Lille |
| Nord |
| 59000 |
| France |
| Centre hospitaliere universitaire | Bordeaux | 33404 | France |
| Centre hospitalier universitaire | Caen | 14033 | France |
| Centre hospitalier régional universitaire | Clermont-Ferrand | 63003 | France |
| Centre hospitalier universitaire | Dijon | 21079 | France |
| Centre hospitalier régional universitaire | Lille | 59037 | France |
| Hospices civils de Lyon | Lyon | 69229 | France |
| Assistance Publique - Hôpitaux de Marseille | Marseille | 13354 | France |
| Centre hospitalier universitaire | Nancy | 54035 | France |
| Centre hospitalier universitaire | Nîmes | 30029 | France |
| Centre hospitalier intercommunal | Poissy | 78303 | France |
| Centre hospitalier régional universtaire | Strasbourg | 67091 | France |
| D003711 | Demyelinating Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
| D002908 | Chronic Disease |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D014947 | Wounds and Injuries |